Saoussen Oueslati

2.2k total citations · 1 hit paper
65 papers, 1.6k citations indexed

About

Saoussen Oueslati is a scholar working on Molecular Medicine, Pharmacology and Endocrinology. According to data from OpenAlex, Saoussen Oueslati has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Medicine, 23 papers in Pharmacology and 22 papers in Endocrinology. Recurrent topics in Saoussen Oueslati's work include Antibiotic Resistance in Bacteria (52 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Bacterial Identification and Susceptibility Testing (17 papers). Saoussen Oueslati is often cited by papers focused on Antibiotic Resistance in Bacteria (52 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers) and Bacterial Identification and Susceptibility Testing (17 papers). Saoussen Oueslati collaborates with scholars based in France, United States and Lebanon. Saoussen Oueslati's co-authors include Thierry Naas, Laurent Dortet, Rémy A. Bonnin, Bogdan I. Iorga, Pascal Retailleau, Agustín Jacinto Zavala, Laura Dabos, Patrice Nordmann, Sandrine Bernabeu and Laurent Poirel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Scientific Reports.

In The Last Decade

Saoussen Oueslati

58 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beta-lactamase database (BLDB) – structure and function

2017 455 citations Thierry Naas, Saoussen Oueslati et al. Journal of Enzyme Inhibition and Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saoussen Oueslati France	20	1.3k	539	413	344	330	65	1.6k
Sandrine Bernabeu France	23	1.8k 1.3×	843 1.6×	387 0.9×	486 1.4×	389 1.2×	46	1.9k
Anna Baraniak Poland	25	1.4k 1.0×	741 1.4×	215 0.5×	189 0.5×	390 1.2×	56	1.6k
Fernando Pasterán Argentina	21	1.2k 0.9×	661 1.2×	279 0.7×	279 0.8×	260 0.8×	74	1.4k
Carla López-Causapé Spain	21	1.6k 1.2×	281 0.5×	445 1.1×	183 0.5×	982 3.0×	69	2.0k
Zhihui Zhou China	19	1.1k 0.8×	466 0.9×	226 0.5×	94 0.3×	580 1.8×	51	1.5k
Hesna Yigit United States	9	1.5k 1.2×	664 1.2×	448 1.1×	288 0.8×	387 1.2×	10	1.7k
Abiola Olumuyiwa Olaitan France	18	1.5k 1.1×	523 1.0×	386 0.9×	131 0.4×	434 1.3×	25	1.9k
Xiaoxing Du China	20	1.6k 1.2×	650 1.2×	478 1.2×	212 0.6×	340 1.0×	45	1.7k
Aggeliki Poulou Greece	25	1.6k 1.2×	741 1.4×	446 1.1×	366 1.1×	348 1.1×	36	1.8k
Michael Hornsey United Kingdom	20	1.4k 1.0×	521 1.0×	492 1.2×	113 0.3×	359 1.1×	25	1.6k

Countries citing papers authored by Saoussen Oueslati

Since Specialization

Citations

This map shows the geographic impact of Saoussen Oueslati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saoussen Oueslati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saoussen Oueslati more than expected).

Fields of papers citing papers by Saoussen Oueslati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saoussen Oueslati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saoussen Oueslati. The network helps show where Saoussen Oueslati may publish in the future.

Co-authorship network of co-authors of Saoussen Oueslati

This figure shows the co-authorship network connecting the top 25 collaborators of Saoussen Oueslati. A scholar is included among the top collaborators of Saoussen Oueslati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saoussen Oueslati. Saoussen Oueslati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salnikov, Evgeniy S., Christopher Aisenbrey, Saoussen Oueslati, et al.. (2025). Cathelicidin-BF: A Potent Antimicrobial Peptide Leveraging Charge and Phospholipid Recruitment against Multidrug-Resistant Clinical Bacterial Isolates. Journal of the American Chemical Society. 147(13). 11199–11215. 4 indexed citations

Oueslati, Saoussen, Delphine Girlich, Laurent Dortet, et al.. (2025). Clonal Dissemination of NDM-Producing Proteus mirabilis in a Teaching Hospital in Sousse, Tunisia. Pathogens. 14(3). 298–298. 3 indexed citations

Mo, Solveig Sølverød, Nicolas Cabanel, Silje Bakken Jørgensen, et al.. (2025). A comparative study of the molecular characteristics of human uropathogenic Escherichia coli collected from two hospitals in Norway and France in 2019. Journal of Antimicrobial Chemotherapy. 80(6). 1707–1715.

Kassem, Issmat I., Khaled El Omari, Nahla O. Eltai, et al.. (2024). Genomic characterization of plasmid-borne colistin resistance variants, mcr-1.1 and mcr-1.26, in multidrug-resistant Escherichia coli isolated from backyard farm animals. Journal of Global Antimicrobial Resistance. 38. 194–197. 1 indexed citations

Oueslati, Saoussen, Laurent Dortet, Katie L. Hopkins, et al.. (2024). Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181. Microorganisms. 12(7). 1391–1391. 5 indexed citations

Oueslati, Saoussen, et al.. (2024). Antibiotic Susceptibility Profiles of Bacterial Isolates Recovered from Abscesses in Cattle and Sheep at a Slaughterhouse in Algeria. Microorganisms. 12(3). 524–524.

Oueslati, Saoussen, Elodie Creton, Rémy A. Bonnin, et al.. (2024). Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant. Antimicrobial Agents and Chemotherapy. 68(5). e0018024–e0018024.

Pfennigwerth, Niels, Saoussen Oueslati, Sören Gatermann, et al.. (2023). In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics. 12(8). 1265–1265. 2 indexed citations

Patiño‐Navarrete, Rafael, Isabelle Rosinski‐Chupin, Nicolas Cabanel, et al.. (2022). Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015. mSystems. 7(1). e0116921–e0116921. 10 indexed citations

10.

Oueslati, Saoussen, et al.. (2022). Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for Acinetobacter baumannii Group with Shortened Time-to-Result: rCIM-A. Pathogens 2022, 11, 482. Pathogens. 11(7). 751–751.

11.

Oueslati, Saoussen, Mohamed Benchekroun, Sandrine Ventre, et al.. (2021). Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). European Journal of Medicinal Chemistry. 219. 113418–113418. 17 indexed citations

12.

Guérin, François, Vincent Cattoir, Elodie Creton, et al.. (2021). Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers. Journal of Antimicrobial Chemotherapy. 76(9). 2294–2301. 7 indexed citations

13.

Dortet, Laurent, Cécile Emeraud, Saoussen Oueslati, et al.. (2021). Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation. Proceedings of the National Academy of Sciences. 118(12). 40 indexed citations

14.

Girlich, Delphine, Saoussen Oueslati, Sandrine Bernabeu, et al.. (2019). Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs. Journal of Molecular Diagnostics. 22(2). 294–300. 22 indexed citations

15.

Naas, Thierry, Saoussen Oueslati, Sandrine Bernabeu, et al.. (2018). Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. International Journal of Antimicrobial Agents. 52(6). 916–921. 35 indexed citations

16.

Oueslati, Saoussen, Laura Dabos, Agustín Jacinto Zavala, Bogdan I. Iorga, & Thierry Naas. (2018). A greater than expected variability among OXA-48-like carbapenemases. SPIRE - Sciences Po Institutional REpository. 1 indexed citations

17.

Naas, Thierry, Saoussen Oueslati, Rémy A. Bonnin, et al.. (2017). Beta-lactamase database (BLDB) – structure and function. Journal of Enzyme Inhibition and Medicinal Chemistry. 32(1). 917–919. 455 indexed citations breakdown →

18.

Bogaerts, Pierre, Saoussen Oueslati, Danièle Meunier, et al.. (2017). Multicentre evaluation of the BYG Carba v2.0 test, a simplified electrochemical assay for the rapid laboratory detection of carbapenemase-producing Enterobacteriaceae. Scientific Reports. 7(1). 9937–9937. 18 indexed citations

19.

Boutal, Hervé, Sandrine Bernabeu, Karine Devilliers, et al.. (2017). A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 73(4). 909–915. 168 indexed citations

20.

Dortet, Laurent, Saoussen Oueslati, Katy Jeannot, et al.. (2015). Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity. Antimicrobial Agents and Chemotherapy. 59(7). 3823–3828. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact